% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • b_zerkley b_zerkley Apr 24, 2000 9:34 AM Flag

    Insider buying?

    The market potential for Alzheimer's diagnostics
    (screening and monitoring therapy) is estimated to be
    $6-800M in the US alone. Quite frankly, I didn't acquire
    this stock with the drug therapy in mind...rather to
    play the diagnostic products. Unless NYMX gets a BIG
    Pharma partner to develop any compound, they should
    stick to the diagnostic side. The Serex thing gives
    them a number of new and exciting options there. Hey,
    just one investors opinion...p.s. love your screen

3.23-0.03(-0.92%)Sep 29 3:59 PMEDT